Neurocrine Biosciences Inc. Earnings

Neurocrine Biosciences Inc.’s revenue jumped 27.78% since last year same period to $794.9Mn in the Q3 2025. On a quarterly growth basis, Neurocrine Biosciences Inc. has generated 15.62% jump in its revenue since last 3-months.

Neurocrine Biosciences Inc.’s net profit jumped 61.4% since last year same period to $209.5Mn in the Q3 2025. On a quarterly growth basis, Neurocrine Biosciences Inc. has generated 94.88% jump in its net profits since last 3-months.

Neurocrine Biosciences Inc.’s net profit margin jumped 26.32% since last year same period to 26.36% in the Q3 2025. On a quarterly growth basis, Neurocrine Biosciences Inc. has generated 68.55% jump in its net profit margins since last 3-months.

Neurocrine Biosciences Inc.’s earning per share (EPS) estimates for the current quarter stand at 1.81 - a -13.4% fall from last quarter’s estimates.

Neurocrine Biosciences Inc.’s earning per share (EPS) estimates for the current year stand at 1.81.

Neurocrine Biosciences Inc.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q4 2025. This indicates that the Neurocrine Biosciences Inc. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.